DrugDashboards

Sennosides, Docusate Sodium

Sennosides, Docusate Sodium · DOCUSATE SODIUM 50 mg/1; SENNOSIDES 8.6 mg/1 · Tablet, Film Coated · Oral · Major Pharmaceuticals

NDC 00904-7440-61 · 10 BLISTER PACK in 1 BOX, UNIT-DOSE / 10 TABLET, FILM COATED in 1 BLISTER PACK · OTC MONOGRAPH DRUG · View full market →

The short version

Just 2 companies supply this market — thin enough that a single exit would be felt immediately. The price has held steady around $0.0303 per unit over the past year. Put together: this looks like a healthy supply — the boring kind, which is exactly what you want.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

Medicare Part D does not cover over-the-counter drugs — by law it pays only for products requiring a prescription.

How Part D pricing works →

NADAC price per unit

$0$0.02$0.04Sep 2024Sep 2026$0.0303
25 price points · per EASource: CMS NADAC

Estimated fill cost

#30 count
$0.91
#90 count
$2.73

Estimates: latest NADAC unit price × quantity. Pharmacy acquisition cost only — excludes dispensing fees, markup, and insurance terms.

Medicaid spend (2025)

$22,521
4,618 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

20Low risk

Some pressure is visible, but not much — here’s everything the score found to count.

  • 2 active manufacturers+20

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for docusate sodium and sennosides (oral solid) in the next 90 days

sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Regulatory

Application
M007
TE code
Approval date
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Sennosides, Docusate Sodium (Tablet, Film Coated)

LabelerStrengthFirst seenLast seen
Cardinal Health 107, LLCDOCUSATE SODIUM 50 mg/1; SENNOSIDES 8.6 mg/1Jul 15, 2026Sep 2, 2026
Major PharmaceuticalsDOCUSATE SODIUM 50 mg/1; SENNOSIDES 8.6 mg/1Jul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Sennosides, Docusate Sodium — NDC 00904-7440-61," retrieved September 3, 2026, https://drugdashboards.com/drug/00904744061.

Free to cite with attribution — see how the data is put together.